JHJRX
Price
$25.11
Change
-$0.74 (-2.86%)
Updated
Dec 18 closing price
VTSAX
Price
$141.29
Change
-$4.58 (-3.14%)
Updated
Dec 18 closing price
Ad is loading...

JHJRX vs VTSAX

Header iconJHJRX vs VTSAX Comparison
Open Charts JHJRX vs VTSAXBanner chart's image
JHancock ESG Large Cap Core R6
Price$25.11
Change-$0.74 (-2.86%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Adm
Price$141.29
Change-$4.58 (-3.14%)
VolumeN/A
CapitalizationN/A
JHJRX vs VTSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JHJRX vs. VTSAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JHJRX is a StrongBuy and VTSAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.84T vs. JHJRX (147M). VTSAX pays higher dividends than JHJRX: VTSAX (1.35) vs JHJRX (0.77). JHJRX was incepted earlier than VTSAX: JHJRX (9 years) vs VTSAX (24 years). JHJRX is a more actively managed with annual turnover of: 12.00 vs. VTSAX (2.00). VTSAX has a lower initial minimum investment than JHJRX: VTSAX (3000) vs JHJRX (1000000). JHJRX (22.17) and VTSAX (22.05) have marching annual gain over last year. VTSAX return over 5 years is better than : 77.49 vs. JHJRX (73.42).
JHJRXVTSAXJHJRX / VTSAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years24 years-
Gain YTD21.13422.42294%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets147M1.84T0%
Annual Yield % from dividends0.771.3557%
Returns for 1 year22.1722.05101%
Returns for 3 years21.5523.8790%
Returns for 5 years73.4277.4995%
Returns for 10 yearsN/A183.58-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNA9.610.18
+1.91%
Ginkgo Bioworks Holdings
TRX0.33N/A
+0.27%
TRX Gold Corp
FIVE105.050.05
+0.05%
Five Below
PSEC4.37-0.01
-0.23%
Prospect Capital Corp
PCSA1.01-0.03
-2.88%
Processa Pharmaceuticals